Tvardi Therapeutics
-
Ticker
TVRD
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Sugar Land, Texas
Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases with significant unmet need.
REPORT RATINGS
4.8 / 5.0 (78)
Tvardi Therapeutics reports have an aggregate usefulness score of 4.8 based on 78 reviews.
Tvardi Therapeutics
Most Recent Responsibility Report
MOST RECENT
2023 Environmental, Social and Governance Report
Report Locked. Tvardi Therapeutics has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Tvardi Therapeutics Sustainability Report, Tvardi Therapeutics Corporate Social Responsibility Report, Tvardi Therapeutics CSR Report, Tvardi Therapeutics Corporate Responsibility, Tvardi Therapeutics CR Report, Tvardi Therapeutics Citizenship Report, Tvardi Therapeutics ESG Report, and Tvardi Therapeutics Environmental Report online.